Article - 13 Jun 2002
Pyrolytic carbon is biocompatible and thromboresistant. This combined with wear resistance, durability and strength make it an ideal material for artificial heart valves. The development of the...
Article - 11 Jan 2003
Titanium alloys are suited to use in both surgical tools and implants. Material properties that contribute to the suitability, alloys that are used and appplications such as bone and joint...
News - 10 Nov 2014
Experts will unveil a new 3D-printed model of the heart at EuroEcho-Imaging 2014, the official European Association of Cardiovascular Imaging (EACVI) annual meeting that is set to take place at the...
News - 4 Jun 2009
Scientists and engineers at UC Santa Barbara and other researchers have developed a nanoparticle that can attack plaque - a major cause of cardiovascular disease. The new development is described in a...
News - 5 Mar 2009
Scientists of the national German metrology institute, the Physikalisch-Technische Bundesanstalt (PTB), have developed a highly sensitive measuring method with which the efficiency of gene transfer in...
News - 23 Feb 2009
Medtronic, Inc. (NYSE: MDT) announced today it has signed a definitive agreement to acquire CoreValve, Inc., developer of a transcatheter, transfemoral aortic valve replacement product. This...
News - 21 May 2014
Dassault Systèmes, the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, today unveiled the world’s first 3D...
News - 15 Sep 2016
TA Instruments introduces the new DuraPulse™ Stent Graft Test (SGT) instrument. For more than 20 years ElectroForce stent/graft test instruments have been trusted with accelerating...
News - 22 Mar 2009
The first peer-reviewed materials database to support medical device design has reached a significant milestone, now providing a total of 22,000 datasheets and literature references for 10,661...
Article - 27 Mar 2020
Researchers have developed electroactive polymer patches to repair damaged heart tissues following cardiovascular events such as stroke and myocardial infarctions.